Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 10 Jun 2024 12:48:03 +0200Thu, 06 Jun 2024 15:14:00 +0200Opinion/decision on a Paediatric investigation plan (PIP): Translarna, Ataluren, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: P/0196/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000115-pip01-07-m13Opinion/decision on a Paediatric investigation plan (PIP): Translarna, Ataluren, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neurology, PIP number: P/0196/2023https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000115-pip01-07-m13Thu, 06 Jun 2024 15:14:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Translarna, ataluren, Date of authorisation: 31/07/2014, Revision: 23, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/translarnaHuman medicines European public assessment report (EPAR): Translarna, ataluren, Date of authorisation: 31/07/2014, Revision: 23, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/translarnaMon, 15 Apr 2024 15:52:00 +0200Human medicineTranslarna : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-2720_en.pdfTranslarna : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-2720_en.pdfTue, 25 Apr 2023 19:31:00 +0200Human medicine